Monitoring IV Antibiotic Use at Home to Reduce Hospital Readmissions
IV Ensure in Patients Receiving OPAT
This study is testing if using a remote monitoring device can help people taking IV antibiotics at home stick to their treatment plan and reduce the chances of them going back to the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IV Ensure Industry-sponsored |
| Locations | 1 site (Oklahoma City, Oklahoma) |
| Trial ID | NCT06623318 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of remote therapeutic monitoring for patients receiving intravenous (IV) antibiotics at home after hospital discharge. It aims to determine the correlation between adherence to prescribed IV medication regimens and hospital readmission rates. By utilizing a remote monitoring device, the study collects data on medication administration to enable timely interventions by care managers, thereby improving patient adherence and outcomes. The primary objectives include measuring adherence rates and assessing their impact on readmission rates.
Who should consider this trial
Good fit: Ideal candidates are adult patients enrolled in outpatient parenteral antibiotic therapy (OPAT) who are discharged to home care.
Not a fit: Patients discharged to nursing homes, skilled nursing facilities, or those who are pediatric patients may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce hospital readmission rates for patients on IV antibiotics at home.
How similar studies have performed: Other studies have shown promising results with remote monitoring approaches in improving adherence and reducing readmissions, indicating potential success for this method.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients enrolled in OPAT (IV antibiotic therapy) discharged to the home setting will be included in the study. Exclusion Criteria: * Patients enrolled in OPAT (IV antibiotic therapy) discharged to nursing homes, SNF (Skilled Nursing Facility), and pediatric patients will be excluded from the study.
Where this trial is running
Oklahoma City, Oklahoma
- The University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States (Recruiting)
Study contacts
- Principal investigator: Joseph Sassine, MD, FACP — The University of Oklahoma Health Sciences Center
- Study coordinator: Mitchell T Berenson, MPH
- Email: mitchell@ivensure.com
- Phone: 214-924-6951
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.